BIOBLAST PHARMA

bioblast-pharma-logo

Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Bio Blast Pharma Ltd. was founded in 2012 and is headquartered in Tel Aviv, Israel. The board has approved the nomination of the following individuals to serve as members of the Board, effective on July 31: Gili Cohen; Eyal Gibor; Tomer Yossef; and Ran Weinstock. All the new members of the board qualify as independent directors under applicable Nasdaq rules.

#SimilarOrganizations #People #Website #More

BIOBLAST PHARMA

Industry:
Biotechnology Genetics Health Care

Founded:
2012-01-01

Address:
Tel Aviv, Tel Aviv, Israel

Country:
Israel

Website Url:
http://www.bioblast-pharma.com

Total Employee:
11+

Status:
Active

Contact:
+972 72-240-9060

Total Funding:
4.75 M USD

Technology used in webpage:
Domain Not Resolving IPv6 Cloudflare Hosting ASP.NET Cloudflare DNS Google Analytics Classic


Similar Organizations

curegenetics-logo

CureGenetics

Cure Genetics is a biotechnology company that develops innovative medicines & molecular diagnostics to treat cancers & genetic diseases.

oncohost-logo

OncoHost

OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Founder


dalia-megiddo_image

Dalia Megiddo

Stock Details


Company's stock symbol is NASDAQ:ORPN

Official Site Inspections

http://www.bioblast-pharma.com

  • Host name: 172.67.138.186
  • IP address: 172.67.138.186
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "BioBlast Pharma"

Pipeline - Bioblast Pharma

At Bioblast Pharma, we develop innovative treatment of organ failure associated with Sepsis and COVID-19, prevention of post-bone marrow transplantations (BMT) complications and solid โ€ฆSee details»

BioBlast Pharma - Crunchbase Company Profile & Funding

Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Bio Blast Pharma Ltd. was founded in 2012 and is โ€ฆSee details»

Bioblast Pharma - Israeli Startup | Startup Nation Finder

Bioblast Pharma is a biotechnology company that develops therapies for patients with rare and ultra-rare genetic diseases. The company is building a diverse portfolio of product candidates โ€ฆSee details»

Organization | Bioblast Pharma Ltd.

Organization Overview. First Clinical Trial. 2014 NCT02015481. First Marketed Drug. None First NDA Approval. None Last Known Activity ... Bioblast Pharma Ltd. Active Ingredients. Drugs in โ€ฆSee details»

BioBlast Pharma - Crunchbase

Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. New. Resources. ... Experience the new โ€ฆSee details»

About Our Company - Bioblast Pharma

Bioblast Pharma provides you with the remedies for particular illnesses involving the same pathogens. Taking into account the concern of modern sciences and health professionals in โ€ฆSee details»

Bioblast Pharma Ltd. - Cruelty Free Investing

Bioblast Pharma Ltd (BioBlast) is an Israel-based development-stage biopharmaceutical company. The Company is focused on the identification, licensing, acquisition, development โ€ฆSee details»

Bioblast Pharma - 2025 Company Profile - Tracxn

Feb 24, 2025 Bioblast Pharma - Israeli clinical-stage Biotech developing therapeutics for rare and ultra-rare genetic diseases.. Public Company. Raised a total funding of $4.75M over 1 โ€ฆSee details»

BioBlast Pharma Strengthens Leadership Team and Announces Key ...

Nov 19, 2015 BioBlast Pharma is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic diseases.See details»

BioBlast Pharma - VentureRadar

BioBlast Pharma manufactures Trehalose, a therapeutic to potentially treat a number of devastating PolyA/PolyQ diseases. Trehalose acts as a chemical chaperone to protects โ€ฆSee details»

Bioblast Pharmaceuticals - Hope Should Not Be Rare

Bioblast pharmaceuticals represents a reputable company specializing in the researches of biotechnologies as well as development of clinically approved treatment solutions for patients โ€ฆSee details»

BioBlast Pharma - Overview, News & Similar companies - ZoomInfo

Feb 18, 2019 BioBlast Pharma is a clinical-stage biotechnology company committed to developing clinically meaningful therapies for patients with rare and ultra-rare genetic โ€ฆSee details»

BioBlast Pharma - PitchBook

BioBlast Pharma General Information Description. Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and โ€ฆSee details»

BioBlast Pharma - Funding, Financials, Valuation & Investors

Bio Blast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases. Search Crunchbase Start Free TrialSee details»

Bioblast Pharma Company Information - Funding, Investors, and โ€ฆ

Get information on funding, investors, industries, and more for Bioblast Pharma. See Bioblast Pharma company profile and funding data.See details»

Our Investors - Bioblast Pharma

The total investment of Bioblast Pharma in the project at the first stage, including the cost of equipping the laboratory with equipment, will amount to about $200 million by the end of 2020. โ€ฆSee details»

Cell Immunotherapy Company Enlivex Merges With Nasdaq-Listed โ€ฆ

Mar 28, 2019 Enlivex completed on Tuesday its merger with Tel Aviv-headquartered Bioblast Pharma Ltd., a Nasdaq-listed clinical-stage company developing treatments for rare genetic โ€ฆSee details»

Support and Resources - Bioblast Pharma

Bioblast Pharma drug prequalification program also performs prequalification of pharmaceutical ingredients and quality control in laboratories. This service is required to assess the quality, โ€ฆSee details»

The Orphan Genetic Disease Company - Bioblast Pharma

Bioblast Pharma Ltd. June 2016 . Forward-Looking Statements This presentation includes statements that are, or may be deemed, โ€˜โ€˜forward-looking statements.โ€™โ€™ In some cases, these โ€ฆSee details»

linkstock.net © 2022. All rights reserved